Fig. 3From: Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinomaSensitivities of FGF19, AFP, and DCP for HCC detection as per the UICC stages. Although FGF19 (a) remained constant at approximately 50% independent of UICC stages, AFP (b), and DCP (c) showed high sensitivity in the advanced stages but not in the early stagesBack to article page